139 related articles for article (PubMed ID: 36764283)
1. Fexofenadine protects against lipopolysaccharide-induced acute lung injury by targeting cytosolic phospholipase A2.
Chen Y; Liu H; Tian Y; Luo Z; Ran J; Miao Z; Zhang Q; Yin G; Xie Q
Int Immunopharmacol; 2023 Mar; 116():109637. PubMed ID: 36764283
[TBL] [Abstract][Full Text] [Related]
2. 23-O-acetylshengmanol-3-O-α-L-arabinoside alleviates lipopolysaccharide-induced acute lung injury through inhibiting IκB/NF-κB and MAPK/AP-1 signaling pathways.
Chen C; Li L; Liu X; Zhang D; Liu Y; Li Y
J Ethnopharmacol; 2023 Jan; 300():115725. PubMed ID: 36115602
[TBL] [Abstract][Full Text] [Related]
3. Isorhamnetin protects mice from lipopolysaccharide-induced acute lung injury via the inhibition of inflammatory responses.
Chi G; Zhong W; Liu Y; Lu G; Lü H; Wang D; Sun F
Inflamm Res; 2016 Jan; 65(1):33-41. PubMed ID: 26525359
[TBL] [Abstract][Full Text] [Related]
4. A CRTH2 antagonist, CT-133, suppresses NF-κB signalling to relieve lipopolysaccharide-induced acute lung injury.
Hussain M; Xu C; Wu X; Lu M; Tang L; Wu F; Wu X; Wu J
Eur J Pharmacol; 2019 Jul; 854():79-91. PubMed ID: 30951719
[TBL] [Abstract][Full Text] [Related]
5. Phospholipase Cε plays a crucial role in neutrophilic inflammation accompanying acute lung injury through augmentation of CXC chemokine production from alveolar epithelial cells.
Umezawa K; Nagano T; Kobayashi K; Dokuni R; Katsurada M; Yamamoto M; Yoshikawa Y; Kataoka T; Nishimura Y
Respir Res; 2019 Jan; 20(1):9. PubMed ID: 30634975
[TBL] [Abstract][Full Text] [Related]
6. Cavidine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via NF-κB Signaling Pathway in vivo and in vitro.
Niu X; Liu F; Li W; Zhi W; Zhang H; Wang X; He Z
Inflammation; 2017 Aug; 40(4):1111-1122. PubMed ID: 28365871
[TBL] [Abstract][Full Text] [Related]
7. Topotecan Alleviates Lipopolysaccharide-Mediated Acute Lung Injury Via the NF-κB Signaling Pathway.
Jin J; Xu W; Wan B; Wang X; Zhou Z; Miao Y; Lv T; Song Y
J Surg Res; 2019 Mar; 235():83-92. PubMed ID: 30691855
[TBL] [Abstract][Full Text] [Related]
8. Fexofenadine inhibits TNF signaling through targeting to cytosolic phospholipase A2 and is therapeutic against inflammatory arthritis.
Liu R; Chen Y; Fu W; Wang S; Cui Y; Zhao X; Lei ZN; Hettinghouse A; Liu J; Wang C; Zhang C; Bi Y; Xiao G; Chen ZS; Liu CJ
Ann Rheum Dis; 2019 Nov; 78(11):1524-1535. PubMed ID: 31302596
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rg3 ameliorates lipopolysaccharide-induced acute lung injury in mice through inactivating the nuclear factor-κB (NF-κB) signaling pathway.
Cheng Z; Li L
Int Immunopharmacol; 2016 May; 34():53-59. PubMed ID: 26921732
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of olopatadine hydrochloride against LPS-induced acute lung injury: via targeting NF-κB signaling pathway.
Kaur J; Rana P; Matta T; Sodhi RK; Pathania K; Pawar SV; Kuhad A; Kondepudi KK; Kaur T; Dhingra N; Sah SP
Inflammopharmacology; 2024 Feb; 32(1):603-627. PubMed ID: 37847473
[TBL] [Abstract][Full Text] [Related]
11. PIM1 inhibitor SMI-4a attenuated lipopolysaccharide-induced acute lung injury through suppressing macrophage inflammatory responses via modulating p65 phosphorylation.
Wang J; Cao Y; Liu Y; Zhang X; Ji F; Li J; Zou Y
Int Immunopharmacol; 2019 Aug; 73():568-574. PubMed ID: 31203114
[TBL] [Abstract][Full Text] [Related]
12. Transcription factor NF-κB promotes acute lung injury
Zhao J; Xie F; Chen R; Zhang Z; Dai R; Zhao N; Wang R; Sun Y; Chen Y
J Biol Chem; 2020 Dec; 295(52):18638-18648. PubMed ID: 33109608
[TBL] [Abstract][Full Text] [Related]
13. Sichen Formula Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via Blocking the TLR4 Signaling Pathways.
Yan LS; Cui S; Cheng BC; Yin XB; Wang YW; Qiu XY; Nima CR; Zhang Y; Zhang SF
Drug Des Devel Ther; 2023; 17():297-312. PubMed ID: 36756190
[TBL] [Abstract][Full Text] [Related]
14. Downregulated microRNA-27b attenuates lipopolysaccharide-induced acute lung injury via activation of NF-E2-related factor 2 and inhibition of nuclear factor κB signaling pathway.
Huang Y; Huang L; Zhu G; Pei Z; Zhang W
J Cell Physiol; 2019 May; 234(5):6023-6032. PubMed ID: 30584668
[TBL] [Abstract][Full Text] [Related]
15. Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury in rats by inhibition of caveolin-1 downstream signaling.
Liu J; Huang X; Hu S; He H; Meng Z
Biomed Pharmacother; 2019 Oct; 118():109314. PubMed ID: 31545263
[TBL] [Abstract][Full Text] [Related]
16. Hederasaponin C Alleviates Lipopolysaccharide-Induced Acute Lung Injury
Han S; Yuan R; Cui Y; He J; Wang QQ; Zhuo Y; Yang S; Gao H
Front Immunol; 2022; 13():846384. PubMed ID: 35281058
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of taraxasterol on acute lung injury induced by lipopolysaccharide in mice.
San Z; Fu Y; Li W; Zhou E; Li Y; Song X; Wang T; Tian Y; Wei Z; Yao M; Cao Y; Zhang N
Int Immunopharmacol; 2014 Apr; 19(2):342-50. PubMed ID: 24548765
[TBL] [Abstract][Full Text] [Related]
18. Cytosolic Phospholipase A2 Is Required for Fexofenadine's Therapeutic Effects against Inflammatory Bowel Disease in Mice.
Zhao X; Liu R; Chen Y; Hettinghouse A; Liu C
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681815
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of methyl salicylate 2-O-β-d-lactoside on LPS-induced acute lung injury by inhibiting TAK1/NF-kappaB phosphorylation and NLRP3 expression.
Yang S; Yu Z; Yuan T; Wang L; Wang X; Yang H; Sun L; Wang Y; Du G
Int Immunopharmacol; 2016 Nov; 40():219-228. PubMed ID: 27620503
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of miR-let-7e attenuates LPS-induced acute lung injury in mice via inhibiting pulmonary inflammation by targeting SCOS1/NF-κB pathway.
Li W; Zhang W; Liu J; Han Y; Jiang H; Ji G; Liu W
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33392621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
